Global Human Blood Plasma Fractionation Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 06 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
According to our (Global Info Research) latest study, the global Human Blood Plasma Fractionation market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Human Blood Plasma Fractionation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Human Blood Plasma Fractionation market size and forecasts, in consumption value ($ Million), 2018-2029
Global Human Blood Plasma Fractionation market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Human Blood Plasma Fractionation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Human Blood Plasma Fractionation market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Blood Plasma Fractionation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Blood Plasma Fractionation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma and Kedrion, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Human Blood Plasma Fractionation market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Immune Globulin
    Coagulation Factor
    Albumin
    Others

Market segment by Application
    Hospital
    Retail Pharmacy
    Others

Market segment by players, this report covers
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Human Blood Plasma Fractionation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Human Blood Plasma Fractionation, with revenue, gross margin and global market share of Human Blood Plasma Fractionation from 2018 to 2023.
Chapter 3, the Human Blood Plasma Fractionation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Human Blood Plasma Fractionation market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Blood Plasma Fractionation.
Chapter 13, to describe Human Blood Plasma Fractionation research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Human Blood Plasma Fractionation
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Human Blood Plasma Fractionation by Type
        1.3.1 Overview: Global Human Blood Plasma Fractionation Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Human Blood Plasma Fractionation Consumption Value Market Share by Type in 2022
        1.3.3 Immune Globulin
        1.3.4 Coagulation Factor
        1.3.5 Albumin
        1.3.6 Others
    1.4 Global Human Blood Plasma Fractionation Market by Application
        1.4.1 Overview: Global Human Blood Plasma Fractionation Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Others
    1.5 Global Human Blood Plasma Fractionation Market Size & Forecast
    1.6 Global Human Blood Plasma Fractionation Market Size and Forecast by Region
        1.6.1 Global Human Blood Plasma Fractionation Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Human Blood Plasma Fractionation Market Size by Region, (2018-2029)
        1.6.3 North America Human Blood Plasma Fractionation Market Size and Prospect (2018-2029)
        1.6.4 Europe Human Blood Plasma Fractionation Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Human Blood Plasma Fractionation Market Size and Prospect (2018-2029)
        1.6.6 South America Human Blood Plasma Fractionation Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Human Blood Plasma Fractionation Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Takeda
        2.1.1 Takeda Details
        2.1.2 Takeda Major Business
        2.1.3 Takeda Human Blood Plasma Fractionation Product and Solutions
        2.1.4 Takeda Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Takeda Recent Developments and Future Plans
    2.2 CSL
        2.2.1 CSL Details
        2.2.2 CSL Major Business
        2.2.3 CSL Human Blood Plasma Fractionation Product and Solutions
        2.2.4 CSL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 CSL Recent Developments and Future Plans
    2.3 Grifols
        2.3.1 Grifols Details
        2.3.2 Grifols Major Business
        2.3.3 Grifols Human Blood Plasma Fractionation Product and Solutions
        2.3.4 Grifols Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Grifols Recent Developments and Future Plans
    2.4 Octapharma
        2.4.1 Octapharma Details
        2.4.2 Octapharma Major Business
        2.4.3 Octapharma Human Blood Plasma Fractionation Product and Solutions
        2.4.4 Octapharma Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Octapharma Recent Developments and Future Plans
    2.5 Kedrion
        2.5.1 Kedrion Details
        2.5.2 Kedrion Major Business
        2.5.3 Kedrion Human Blood Plasma Fractionation Product and Solutions
        2.5.4 Kedrion Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Kedrion Recent Developments and Future Plans
    2.6 LFB Group
        2.6.1 LFB Group Details
        2.6.2 LFB Group Major Business
        2.6.3 LFB Group Human Blood Plasma Fractionation Product and Solutions
        2.6.4 LFB Group Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 LFB Group Recent Developments and Future Plans
    2.7 Biotest
        2.7.1 Biotest Details
        2.7.2 Biotest Major Business
        2.7.3 Biotest Human Blood Plasma Fractionation Product and Solutions
        2.7.4 Biotest Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Biotest Recent Developments and Future Plans
    2.8 BPL
        2.8.1 BPL Details
        2.8.2 BPL Major Business
        2.8.3 BPL Human Blood Plasma Fractionation Product and Solutions
        2.8.4 BPL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 BPL Recent Developments and Future Plans
    2.9 RAAS
        2.9.1 RAAS Details
        2.9.2 RAAS Major Business
        2.9.3 RAAS Human Blood Plasma Fractionation Product and Solutions
        2.9.4 RAAS Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 RAAS Recent Developments and Future Plans
    2.10 CBPO
        2.10.1 CBPO Details
        2.10.2 CBPO Major Business
        2.10.3 CBPO Human Blood Plasma Fractionation Product and Solutions
        2.10.4 CBPO Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 CBPO Recent Developments and Future Plans
    2.11 Hualan Bio
        2.11.1 Hualan Bio Details
        2.11.2 Hualan Bio Major Business
        2.11.3 Hualan Bio Human Blood Plasma Fractionation Product and Solutions
        2.11.4 Hualan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Hualan Bio Recent Developments and Future Plans
    2.12 Tiantan Bio
        2.12.1 Tiantan Bio Details
        2.12.2 Tiantan Bio Major Business
        2.12.3 Tiantan Bio Human Blood Plasma Fractionation Product and Solutions
        2.12.4 Tiantan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Tiantan Bio Recent Developments and Future Plans
    2.13 Shuanglin Bio
        2.13.1 Shuanglin Bio Details
        2.13.2 Shuanglin Bio Major Business
        2.13.3 Shuanglin Bio Human Blood Plasma Fractionation Product and Solutions
        2.13.4 Shuanglin Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Shuanglin Bio Recent Developments and Future Plans
    2.14 Boya Bio
        2.14.1 Boya Bio Details
        2.14.2 Boya Bio Major Business
        2.14.3 Boya Bio Human Blood Plasma Fractionation Product and Solutions
        2.14.4 Boya Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Boya Bio Recent Developments and Future Plans
    2.15 Yuanda Shuyang
        2.15.1 Yuanda Shuyang Details
        2.15.2 Yuanda Shuyang Major Business
        2.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Product and Solutions
        2.15.4 Yuanda Shuyang Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Yuanda Shuyang Recent Developments and Future Plans
    2.16 Weiguang Bio
        2.16.1 Weiguang Bio Details
        2.16.2 Weiguang Bio Major Business
        2.16.3 Weiguang Bio Human Blood Plasma Fractionation Product and Solutions
        2.16.4 Weiguang Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Weiguang Bio Recent Developments and Future Plans
    2.17 Nanyue Bio
        2.17.1 Nanyue Bio Details
        2.17.2 Nanyue Bio Major Business
        2.17.3 Nanyue Bio Human Blood Plasma Fractionation Product and Solutions
        2.17.4 Nanyue Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Nanyue Bio Recent Developments and Future Plans
    2.18 KM Biologics
        2.18.1 KM Biologics Details
        2.18.2 KM Biologics Major Business
        2.18.3 KM Biologics Human Blood Plasma Fractionation Product and Solutions
        2.18.4 KM Biologics Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 KM Biologics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Human Blood Plasma Fractionation Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Human Blood Plasma Fractionation by Company Revenue
        3.2.2 Top 3 Human Blood Plasma Fractionation Players Market Share in 2022
        3.2.3 Top 6 Human Blood Plasma Fractionation Players Market Share in 2022
    3.3 Human Blood Plasma Fractionation Market: Overall Company Footprint Analysis
        3.3.1 Human Blood Plasma Fractionation Market: Region Footprint
        3.3.2 Human Blood Plasma Fractionation Market: Company Product Type Footprint
        3.3.3 Human Blood Plasma Fractionation Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Human Blood Plasma Fractionation Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Human Blood Plasma Fractionation Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2023)
    5.2 Global Human Blood Plasma Fractionation Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Human Blood Plasma Fractionation Consumption Value by Type (2018-2029)
    6.2 North America Human Blood Plasma Fractionation Consumption Value by Application (2018-2029)
    6.3 North America Human Blood Plasma Fractionation Market Size by Country
        6.3.1 North America Human Blood Plasma Fractionation Consumption Value by Country (2018-2029)
        6.3.2 United States Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        6.3.3 Canada Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        6.3.4 Mexico Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Human Blood Plasma Fractionation Consumption Value by Type (2018-2029)
    7.2 Europe Human Blood Plasma Fractionation Consumption Value by Application (2018-2029)
    7.3 Europe Human Blood Plasma Fractionation Market Size by Country
        7.3.1 Europe Human Blood Plasma Fractionation Consumption Value by Country (2018-2029)
        7.3.2 Germany Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        7.3.3 France Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        7.3.5 Russia Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        7.3.6 Italy Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Human Blood Plasma Fractionation Market Size by Region
        8.3.1 Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2018-2029)
        8.3.2 China Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        8.3.3 Japan Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        8.3.4 South Korea Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        8.3.5 India Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        8.3.7 Australia Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Human Blood Plasma Fractionation Consumption Value by Type (2018-2029)
    9.2 South America Human Blood Plasma Fractionation Consumption Value by Application (2018-2029)
    9.3 South America Human Blood Plasma Fractionation Market Size by Country
        9.3.1 South America Human Blood Plasma Fractionation Consumption Value by Country (2018-2029)
        9.3.2 Brazil Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        9.3.3 Argentina Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country
        10.3.1 Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2018-2029)
        10.3.2 Turkey Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)
        10.3.4 UAE Human Blood Plasma Fractionation Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Human Blood Plasma Fractionation Market Drivers
    11.2 Human Blood Plasma Fractionation Market Restraints
    11.3 Human Blood Plasma Fractionation Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Human Blood Plasma Fractionation Industry Chain
    12.2 Human Blood Plasma Fractionation Upstream Analysis
    12.3 Human Blood Plasma Fractionation Midstream Analysis
    12.4 Human Blood Plasma Fractionation Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Human Blood Plasma Fractionation Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Human Blood Plasma Fractionation Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Human Blood Plasma Fractionation Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Takeda Company Information, Head Office, and Major Competitors
    Table 6. Takeda Major Business
    Table 7. Takeda Human Blood Plasma Fractionation Product and Solutions
    Table 8. Takeda Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Takeda Recent Developments and Future Plans
    Table 10. CSL Company Information, Head Office, and Major Competitors
    Table 11. CSL Major Business
    Table 12. CSL Human Blood Plasma Fractionation Product and Solutions
    Table 13. CSL Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. CSL Recent Developments and Future Plans
    Table 15. Grifols Company Information, Head Office, and Major Competitors
    Table 16. Grifols Major Business
    Table 17. Grifols Human Blood Plasma Fractionation Product and Solutions
    Table 18. Grifols Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Grifols Recent Developments and Future Plans
    Table 20. Octapharma Company Information, Head Office, and Major Competitors
    Table 21. Octapharma Major Business
    Table 22. Octapharma Human Blood Plasma Fractionation Product and Solutions
    Table 23. Octapharma Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Octapharma Recent Developments and Future Plans
    Table 25. Kedrion Company Information, Head Office, and Major Competitors
    Table 26. Kedrion Major Business
    Table 27. Kedrion Human Blood Plasma Fractionation Product and Solutions
    Table 28. Kedrion Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Kedrion Recent Developments and Future Plans
    Table 30. LFB Group Company Information, Head Office, and Major Competitors
    Table 31. LFB Group Major Business
    Table 32. LFB Group Human Blood Plasma Fractionation Product and Solutions
    Table 33. LFB Group Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. LFB Group Recent Developments and Future Plans
    Table 35. Biotest Company Information, Head Office, and Major Competitors
    Table 36. Biotest Major Business
    Table 37. Biotest Human Blood Plasma Fractionation Product and Solutions
    Table 38. Biotest Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Biotest Recent Developments and Future Plans
    Table 40. BPL Company Information, Head Office, and Major Competitors
    Table 41. BPL Major Business
    Table 42. BPL Human Blood Plasma Fractionation Product and Solutions
    Table 43. BPL Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. BPL Recent Developments and Future Plans
    Table 45. RAAS Company Information, Head Office, and Major Competitors
    Table 46. RAAS Major Business
    Table 47. RAAS Human Blood Plasma Fractionation Product and Solutions
    Table 48. RAAS Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. RAAS Recent Developments and Future Plans
    Table 50. CBPO Company Information, Head Office, and Major Competitors
    Table 51. CBPO Major Business
    Table 52. CBPO Human Blood Plasma Fractionation Product and Solutions
    Table 53. CBPO Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. CBPO Recent Developments and Future Plans
    Table 55. Hualan Bio Company Information, Head Office, and Major Competitors
    Table 56. Hualan Bio Major Business
    Table 57. Hualan Bio Human Blood Plasma Fractionation Product and Solutions
    Table 58. Hualan Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Hualan Bio Recent Developments and Future Plans
    Table 60. Tiantan Bio Company Information, Head Office, and Major Competitors
    Table 61. Tiantan Bio Major Business
    Table 62. Tiantan Bio Human Blood Plasma Fractionation Product and Solutions
    Table 63. Tiantan Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Tiantan Bio Recent Developments and Future Plans
    Table 65. Shuanglin Bio Company Information, Head Office, and Major Competitors
    Table 66. Shuanglin Bio Major Business
    Table 67. Shuanglin Bio Human Blood Plasma Fractionation Product and Solutions
    Table 68. Shuanglin Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Shuanglin Bio Recent Developments and Future Plans
    Table 70. Boya Bio Company Information, Head Office, and Major Competitors
    Table 71. Boya Bio Major Business
    Table 72. Boya Bio Human Blood Plasma Fractionation Product and Solutions
    Table 73. Boya Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Boya Bio Recent Developments and Future Plans
    Table 75. Yuanda Shuyang Company Information, Head Office, and Major Competitors
    Table 76. Yuanda Shuyang Major Business
    Table 77. Yuanda Shuyang Human Blood Plasma Fractionation Product and Solutions
    Table 78. Yuanda Shuyang Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Yuanda Shuyang Recent Developments and Future Plans
    Table 80. Weiguang Bio Company Information, Head Office, and Major Competitors
    Table 81. Weiguang Bio Major Business
    Table 82. Weiguang Bio Human Blood Plasma Fractionation Product and Solutions
    Table 83. Weiguang Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Weiguang Bio Recent Developments and Future Plans
    Table 85. Nanyue Bio Company Information, Head Office, and Major Competitors
    Table 86. Nanyue Bio Major Business
    Table 87. Nanyue Bio Human Blood Plasma Fractionation Product and Solutions
    Table 88. Nanyue Bio Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Nanyue Bio Recent Developments and Future Plans
    Table 90. KM Biologics Company Information, Head Office, and Major Competitors
    Table 91. KM Biologics Major Business
    Table 92. KM Biologics Human Blood Plasma Fractionation Product and Solutions
    Table 93. KM Biologics Human Blood Plasma Fractionation Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. KM Biologics Recent Developments and Future Plans
    Table 95. Global Human Blood Plasma Fractionation Revenue (USD Million) by Players (2018-2023)
    Table 96. Global Human Blood Plasma Fractionation Revenue Share by Players (2018-2023)
    Table 97. Breakdown of Human Blood Plasma Fractionation by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 98. Market Position of Players in Human Blood Plasma Fractionation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 99. Head Office of Key Human Blood Plasma Fractionation Players
    Table 100. Human Blood Plasma Fractionation Market: Company Product Type Footprint
    Table 101. Human Blood Plasma Fractionation Market: Company Product Application Footprint
    Table 102. Human Blood Plasma Fractionation New Market Entrants and Barriers to Market Entry
    Table 103. Human Blood Plasma Fractionation Mergers, Acquisition, Agreements, and Collaborations
    Table 104. Global Human Blood Plasma Fractionation Consumption Value (USD Million) by Type (2018-2023)
    Table 105. Global Human Blood Plasma Fractionation Consumption Value Share by Type (2018-2023)
    Table 106. Global Human Blood Plasma Fractionation Consumption Value Forecast by Type (2024-2029)
    Table 107. Global Human Blood Plasma Fractionation Consumption Value by Application (2018-2023)
    Table 108. Global Human Blood Plasma Fractionation Consumption Value Forecast by Application (2024-2029)
    Table 109. North America Human Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
    Table 110. North America Human Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
    Table 111. North America Human Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. North America Human Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. North America Human Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
    Table 114. North America Human Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
    Table 115. Europe Human Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
    Table 116. Europe Human Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
    Table 117. Europe Human Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
    Table 118. Europe Human Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
    Table 119. Europe Human Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Human Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
    Table 122. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
    Table 123. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
    Table 124. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
    Table 125. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2018-2023) & (USD Million)
    Table 126. Asia-Pacific Human Blood Plasma Fractionation Consumption Value by Region (2024-2029) & (USD Million)
    Table 127. South America Human Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
    Table 128. South America Human Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
    Table 129. South America Human Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
    Table 130. South America Human Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
    Table 131. South America Human Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
    Table 132. South America Human Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
    Table 133. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Type (2024-2029) & (USD Million)
    Table 135. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2018-2023) & (USD Million)
    Table 136. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Application (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2018-2023) & (USD Million)
    Table 138. Middle East & Africa Human Blood Plasma Fractionation Consumption Value by Country (2024-2029) & (USD Million)
    Table 139. Human Blood Plasma Fractionation Raw Material
    Table 140. Key Suppliers of Human Blood Plasma Fractionation Raw Materials
List of Figures
    Figure 1. Human Blood Plasma Fractionation Picture
    Figure 2. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Human Blood Plasma Fractionation Consumption Value Market Share by Type in 2022
    Figure 4. Immune Globulin
    Figure 5. Coagulation Factor
    Figure 6. Albumin
    Figure 7. Others
    Figure 8. Global Human Blood Plasma Fractionation Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Human Blood Plasma Fractionation Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Picture
    Figure 11. Retail Pharmacy Picture
    Figure 12. Others Picture
    Figure 13. Global Human Blood Plasma Fractionation Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Human Blood Plasma Fractionation Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Human Blood Plasma Fractionation Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Human Blood Plasma Fractionation Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Human Blood Plasma Fractionation Consumption Value Market Share by Region in 2022
    Figure 18. North America Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Human Blood Plasma Fractionation Revenue Share by Players in 2022
    Figure 24. Human Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Human Blood Plasma Fractionation Market Share in 2022
    Figure 26. Global Top 6 Players Human Blood Plasma Fractionation Market Share in 2022
    Figure 27. Global Human Blood Plasma Fractionation Consumption Value Share by Type (2018-2023)
    Figure 28. Global Human Blood Plasma Fractionation Market Share Forecast by Type (2024-2029)
    Figure 29. Global Human Blood Plasma Fractionation Consumption Value Share by Application (2018-2023)
    Figure 30. Global Human Blood Plasma Fractionation Market Share Forecast by Application (2024-2029)
    Figure 31. North America Human Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Human Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Human Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Human Blood Plasma Fractionation Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Human Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Human Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Human Blood Plasma Fractionation Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Human Blood Plasma Fractionation Consumption Value (2018-2029) & (USD Million)
    Figure 65. Human Blood Plasma Fractionation Market Drivers
    Figure 66. Human Blood Plasma Fractionation Market Restraints
    Figure 67. Human Blood Plasma Fractionation Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Human Blood Plasma Fractionation in 2022
    Figure 70. Manufacturing Process Analysis of Human Blood Plasma Fractionation
    Figure 71. Human Blood Plasma Fractionation Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Human Blood Plasma Fractionation Supply, Demand and Key Producers, 2023-2029

Global Human Blood Plasma Fractionation Supply, Demand and Key Producers, 2023-2029

date 28 Jan 2023

date Pharma & Healthcare

The global Human Blood Plasma Fractionation market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Human Blood Plasma Fractionation Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Human Blood Plasma Fractionation Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Blood Plasma Fractionation market size was valued at USD 31210 million in 2023 and is forecast to a readjusted size of USD 51020 million by 2030 with a CAGR of 7.3% during review period.

Global Human Blood Plasma Fractionation Supply, Demand and Key Producers, 2024-2030

Global Human Blood Plasma Fractionation Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Pharma & Healthcare

The global Human Blood Plasma Fractionation market size is expected to reach $ 51020 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

Product Tags

Human Blood Plasma Fractionation

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>